Articles

EMA Decision on Biosimilar Pricing: Key Insights for Oncology Market

The EMA's recent decision on biosimilar pricing offers crucial insights for the oncology market, influencing drug accessibility and treatment options.

PRAC Guidelines Liver Injury: What You Need to Know

Learn about the latest PRAC guidelines on liver injury, focusing on drugs like Paracetamol, to ensure safe and effective pain management.

AI Drug Discovery EU: Accelerating Rare Disease Therapies via COMP & EMA

Discover how AI technology is transforming drug discovery for rare diseases, enhancing the development of therapies under the EU's COMP and EMA frameworks.

Real-World Evidence in EU: Leveraging EHRs for Regulatory Decisions

This article delves into the role of real-world evidence from electronic health records in shaping regulatory decisions for drugs in the EU, improving healthcare delivery.